misleading statements

Upstart Holdings faces class action lawsuit alleging false claims about its AI Model 22 risk assessment tool. Investors can join until June 8, 2026.

Stellantis faces class action over allegedly false earnings forecasts and misrepresented EV strategy. Lawsuit covers shareholders who purchased stock between February 2025 and February 2026.

Law firm announces class action against Gemini Space Station for allegedly misleading investors about crypto platform viability and international expansion between September 2025 and February 2026.

Class action lawsuit filed against Corcept Therapeutics alleging executives made false statements about relacorilant's clinical strength and FDA approval prospects.

Aquestive Therapeutics faces securities lawsuit after FDA Anaphylm deficiency notice triggers 37% stock decline from $6.21 to $3.91 on January 9, 2026.

The Gross Law Firm filed a securities class action against $COTY for allegedly misleading investors about financial performance. Stock fell 22% after weak Q2 results.

Robbins LLP files class action against PSIX over alleged investor fraud involving data center sales forecasts. Stock fell 29% after March 2026 margin decline disclosure.

Investors in Concorde International Group Ltd. ($CIGL) have until May 20, 2026 to join securities class action alleging fraudulent stock promotion and insider dumping.

Coty faces securities lawsuit after revealing 70% Consumer Beauty operating income drop, CEO departure, and withdrawn FY2026 guidance in February.

Rosen Law Firm files UPST class action over Model 22 AI misrepresentations. Alleged false claims about accuracy rates and macroeconomic model sensitivity impact investor viability.

Lakeland Industries faces securities lawsuit over alleged operational misstatements regarding Pacific Helmets and Jolly businesses; April 24, 2026 deadline for losses exceeding $100K.

Coty Inc. faces securities lawsuit over alleged misstatements on beauty market conditions, margins. Lead plaintiff deadline: May 22, 2026.

Class action lawsuit filed against Aldeyra Therapeutics for allegedly false statements on reproxalap trial results, covering investors from November 2023 to March 2026.

Class action lawsuit filed against $EOSE alleging securities fraud over undisclosed production delays, battery downtime, and quality control failures.

RGNX faces class action lawsuit alleging false statements about RGX-111 safety. FDA clinical hold imposed after trial participant developed tumor.

PayPal shareholders targeted in class action alleging misstatements on Branded Checkout initiatives. Stock fell 20.3% following CEO replacement and disappointing earnings.

Law Offices of Howard G. Smith filed securities fraud class actions against $CHOW, $GO, $ALIT, $IT, alleging false statements on operations and finances. Investors must file lead plaintiff motions by mid-May 2026.

Franklin BSP Realty Trust shareholders pursue class action lawsuit after 14.2% stock plunge following dividend reset and disclosure of capital over-distribution to investors.

Hagens Berman alerts $CORT investors to April 21 lead plaintiff deadline in securities fraud class action alleging concealment of FDA concerns about relacorilant ahead of rejection.

Portnoy Law Firm files class action against $SNOW for allegedly concealing negative impact of product efficiency gains on revenues. Stock fell 18% post-disclosure.